Edition:
United Kingdom

OvaScience Inc (OVAS.OQ)

OVAS.OQ on NASDAQ Stock Exchange Global Market

0.95USD
18 May 2018
Change (% chg)

$0.01 (+0.56%)
Prev Close
$0.94
Open
$0.93
Day's High
$0.96
Day's Low
$0.93
Volume
13,594
Avg. Vol
75,872
52-wk High
$1.96
52-wk Low
$0.71

Chart for

About

OvaScience, Inc. is a global fertility company. The Company is focused on the discovery, development and commercialization of fertility treatment options for women. The Company's portfolio of fertility treatment options uses its technology, including methods to identify and isolate Egg precursor (EggPC) cells from a patient's... (more)

Overall

Beta: 3.53
Market Cap(Mil.): $49.96
Shares Outstanding(Mil.): 35.69
Dividend: --
Yield (%): --

Financials

  OVAS.OQ Industry Sector
P/E (TTM): -- 84.06 32.75
EPS (TTM): -2.11 -- --
ROI: -65.22 1.57 14.38
ROE: -65.89 2.43 16.07

BRIEF-Ovascience Reports Q1 Loss Per Share Of $0.21

* OVASCIENCE REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

03 May 2018

BRIEF-AIGH Investment Partners Reports 6.2 Percent Passive Stake In Ovascience Inc As Of March 28, 2018 ‍​

* AIGH INVESTMENT PARTNERS, L.P. REPORTS 6.2 PERCENT PASSIVE STAKE IN OVASCIENCE INC AS OF MARCH 28, 2018 - SEC FILING‍​ Source text : [https://bit.ly/2pOX7po] Further company coverage:

29 Mar 2018

BRIEF-BML Investment Partners Reports 6.4 Pct Passive Stake In Ovascience

* BML INVESTMENT PARTNERS LP REPORTS 6.4 PERCENT PASSIVE STAKE IN OVASCIENCE INC AS OF MARCH 28 - SEC FILING Source text - https://bit.ly/2J1zaDr Further company coverage:

28 Mar 2018

BRIEF-Ovascience Reports Q4 Loss Per Share $0.24

* OVASCIENCE REPORTS FOURTH QUARTER AND YEAR-END 2017 FINANCIAL RESULTS

15 Mar 2018

BRIEF-OvaScience Says Provided Intrexon Corp With Written Notice Of Termination Of Exclusive Channel Collaboration Agreement, Dated Dec 18, 2013

* OVASCIENCE SAYS PROVIDED INTREXON CORP WITH WRITTEN NOTICE OF TERMINATION OF EXCLUSIVE CHANNEL COLLABORATION AGREEMENT, DATED DEC 18, 2013-SEC FILING

01 Feb 2018

BRIEF-Ovascience Says ‍Reducing Headcount By Approximately 50 Percent​

* OVASCIENCE INC - ‍REDUCING HEADCOUNT BY APPROXIMATELY 50 PERCENT​

03 Jan 2018

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $124.24 +0.39
Pfizer Inc. (PFE.N) $35.64 -0.07
Merck & Co., Inc. (MRK.N) $59.14 +0.07
Sanofi SA (SASY.PA) €66.44 +0.32
Eli Lilly And Co (LLY.N) $82.07 +0.41
Abbott Laboratories (ABT.N) $61.71 +0.65

Earnings vs. Estimates